(Q48006982)

7 February 2018

title

IVIg dose increase in multifocal motor neuropathy: a prospective six month follow-up (English)

1 reference

7 February 2018

Multifocal motor neuropathy

main subject

1 reference

Andreas Baumann

1

1 reference

7 February 2018

Christian W Hess

series ordinal

2

1 reference

7 February 2018

Matthias Sturzenegger

series ordinal

3

1 reference

7 February 2018

publication date

9 April 2009

1 reference

7 February 2018

published in

Journal of Neurology

1 reference

7 February 2018

volume

256

1 reference

7 February 2018

issue

4

1 reference

7 February 2018

page(s)

608-614

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1007/s00415-009-0130-0

exact match

0 references

cites work

Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-009-0130-0

Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment.

21 January 2018

1 reference

12 December 2020

The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile

1 reference

12 December 2020

Multifocal motor neuropathy: the diagnostic spectrum and response to treatment

1 reference

12 December 2020

Safety of intravenous immunoglobulin (IVIG) therapy

1 reference

12 December 2020

Side effects of intravenous immunoglobulins in neurological autoimmune disorders--a prospective study

1 reference

12 December 2020

Axon loss is an important determinant of weakness in multifocal motor neuropathy

1 reference

12 December 2020

Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record

1 reference

12 December 2020

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy

1 reference

12 December 2020

Natural history of 46 patients with multifocal motor neuropathy with conduction block

1 reference

12 December 2020

Consensus criteria for the diagnosis of multifocal motor neuropathy

1 reference

12 December 2020

Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease

1 reference

12 December 2020

Multifocal motor neuropathy with conduction block: Distribution of demyelination and axonal degeneration

1 reference

12 December 2020

Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness.

1 reference

12 December 2020

Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.

1 reference

12 December 2020

Intravenous immunoglobulin for multifocal motor neuropathy

1 reference

12 December 2020

The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis.

1 reference

12 December 2020

Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg

1 reference

12 December 2020

10.1007/S00415-009-0130-0

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018